2011

2011 Grants Awarded
“Pseudomyxoma Peritonei: Prognostic Analysis of Micro-RNA and Other Biological Factors Using Tissue Microarray”
Marcello Deraco, MD, Director, Peritoneal Surface Malignancy Management Program, Fondazione IRCCS Instituto Nazionale Tumor (National Cancer Institute), Milano, Italy
$50,000/2 year
Research update from Marcello Deraco, MD, dated 8/7/13
Associated publication: “FOLFOX-4 Chemotherapy for Patients With Unresectable or Relapsed Peritoneal Pseudomyxoma.” (Oncologist. 2014 Aug; 19(8): 845–850)

“Sequencing the Cancer Genome of Mucinous Adenocarcinoma of the Appendix”
Andrew Lowy,MD, Chief, Division of Surgical Oncology, Moores Cancer Center, University of California, San Diego, CA, USA
$50,000/2 year
Associated Publication: “Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin.” (Genome Medicine 2014, 6:43)

“Preclinical Targeting of the Goblet Cell Differentiation Pathway in Pseudomyxoma Peritonei”
Andrew Renehan, PhD, FRCS, Senior Lecturer in Cancer Studies and Surgery, School of Cancer and Enabling Sciences, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK
$50,000/2 year
Research update from Andrew Renehan, PhD, FRCS, dated 8/7/13
Final research update from Andrew Renehan, Phd, FRCS, dated 8/2017